PMV Pharmaceuticals
PMVP
PMVP
106 hedge funds and large institutions have $324M invested in PMV Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
5% less funds holding
Funds holding: 111 → 106 (-5)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
106
Holding in Top 10
3
Calls
$121K
Puts
$21K
Top Buyers
| 1 | +$4.44M | |
| 2 | +$4.05M | |
| 3 | +$3.49M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$2.94M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.17M |
Top Sellers
| 1 | -$4.61M | |
| 2 | -$3.94M | |
| 3 | -$1.9M | |
| 4 |
Morgan Stanley
New York
|
-$1.72M |
| 5 |
HF
HRT Financial
New York
|
-$1.53M |